We are live on ! Find out more
CA

Cullinan Associates Portfolio holdings

AUM $1.24B
1-Year Est. Return 28.12%
This Fund
S&P 500
This Quarter Est. Return
+4.29%
1 Year Est. Return
+28.12%
3 Year Est. Return
+86.66%
5 Year Est. Return
+111.98%
10 Year Est. Return
+372.59%
AUM
$1.23B
AUM Growth
+$59.4M
Cap. Flow
+$16.2M
Cap. Flow %
1.31%
Top 10 Hldgs %
42.86%
Holding
211
New
11
Increased
78
Reduced
63
Closed
10

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$6.27M
2
PAYX icon
Paychex
PAYX
+$3.5M
3
SCHW
Charles Schwab
SCHW
+$2.97M
4
EPD icon
Enterprise Products Partners
EPD
+$2.65M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$2.36M

Top Sells

Rank Stock Value
1
AFL icon
Aflac
AFL
+$3.22M
2
PNC icon
PNC Financial Services
PNC
+$2.38M
3
NEE icon
NextEra Energy
NEE
+$2.23M
4
VZ icon
Verizon
VZ
+$1.82M
5
STJ
St Jude Medical
STJ
+$1.53M

Sector Composition

Rank Sector Weight
1 Consumer Staples 31.24%
2 Healthcare 14.87%
3 Financials 10.21%
4 Technology 9.69%
5 Industrials 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AET
126
DELISTED
Aetna Inc
AET
$1.22M 0.1%
10,000
+4,130
+70% +$474K
IWM icon
127
iShares Russell 2000 ETF
IWM
$80.9B
$1.18M 0.1%
10,245
+290
+3% +$32.7K
HON icon
128
Honeywell
HON
$77.1B
$1.07M 0.09%
10,289
-25
-0.2% -$2.57K
MCHP icon
129
Microchip Technology
MCHP
$42.8B
$1.07M 0.09%
+42,300
New +$1.05M
GS icon
130
Goldman Sachs
GS
$313B
$1.07M 0.09%
7,200
– –
APD icon
131
Air Products & Chemicals
APD
$66.3B
$1.05M 0.09%
7,999
+432
+6% +$57.5K
BAC icon
132
Bank of America
BAC
$435B
$1.03M 0.08%
77,800
– –
TPR icon
133
Tapestry
TPR
$28.8B
$966K 0.08%
+23,700
New +$934K
AMZN icon
134
Amazon
AMZN
$2.5T
$930K 0.08%
26,000
+2,000
+8% +$67.6K
FLS icon
135
Flowserve
FLS
$9.25B
$919K 0.07%
20,350
+7,750
+62% +$363K
TIF
136
DELISTED
Tiffany & Co.
TIF
$897K 0.07%
14,800
+1,000
+7% +$66.5K
ASH icon
137
Ashland
ASH
$3.04B
$870K 0.07%
15,494
– –
DD
138
DELISTED
Du Pont De Nemours E I
DD
$855K 0.07%
13,200
-200
-1% -$13.1K
GM icon
139
General Motors
GM
$74.7B
$849K 0.07%
30,000
+20,800
+226% +$631K
MCK icon
140
McKesson
MCK
$98.5B
$849K 0.07%
+4,550
New +$798K
MSS
141
DELISTED
MILESTONE SCIENTIFIC INC (NEW)
MSS
$831K 0.07%
32,000
– –
EMR icon
142
Emerson Electric
EMR
$82.9B
$830K 0.07%
15,912
-1,100
-6% -$58.4K
WFM
143
DELISTED
Whole Foods Market Inc
WFM
$749K 0.06%
23,400
– –
EOG icon
144
EOG Resources
EOG
$78B
$735K 0.06%
8,810
-3,100
-26% -$248K
FDS icon
145
Factset
FDS
$9.05B
$694K 0.06%
+4,300
New +$665K
GSK icon
146
GSK
GSK
$103B
$662K 0.05%
12,217
+3,760
+44% +$198K
DD icon
147
DuPont de Nemours
DD
$18.6B
$661K 0.05%
5,252
– –
SYK icon
148
Stryker
SYK
$127B
$614K 0.05%
5,125
– –
COP icon
149
ConocoPhillips
COP
$147B
$593K 0.05%
13,600
– –
FSLR icon
150
First Solar
FSLR
$21.8B
$587K 0.05%
12,100
– –
4 5
6
7 8

Similar funds

WTA
Washington Trust Advisors Wellesley, Massachusetts $1.24B AUM 22.58% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
GX
Greylock XIV Menlo Park, California $1.24B AUM
HCA
Harbor Capital Advisors Chicago, Illinois $1.23B AUM 30.56% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
CCA
Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return
FLII
First Long Island Investors Jericho, New York $1.23B AUM 14.42% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Cullinan Associates's Q2 2016 Portfolio in Review

As of Q2 2016, Cullinan Associates held 211 positions worth $1.23B, up 5.1% from $1.17B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Cullinan Associates's Q2 2016 filing shows 11 new, 78 increased, 63 reduced and 10 closed positions. Its largest new stake was Charles Schwab: 104,400 shares worth $2.64M. The largest sale was Aflac, an estimated $3.22M.

By sector, the portfolio is most concentrated in Consumer Staples at 31% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.

  • Cullinan Associates's largest Q2 2016 buy was Charles Schwab: 104,400 shares worth $2.64M.
  • Cullinan Associates added most to Bristol-Myers Squibb in Q2 2016, an estimated $6.27M increase.
  • Cullinan Associates's biggest Q2 2016 reduction was Aflac, cutting an estimated $3.22M.
  • Cullinan Associates fully exited St Jude Medical in Q2 2016, selling an estimated $1.53M.
  • Cullinan Associates's ten largest holdings make up 43% of its $1.23B portfolio in Q2 2016.
  • Cullinan Associates opened 11 new positions and closed 10 in Q2 2016.
  • Cullinan Associates's portfolio value rose 5.1% quarter-over-quarter to $1.23B.

Based on Cullinan Associates's 13F filing for Q2 2016, filed 1 Jul 2016.